Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Vivus Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 13
» View wsbt.com items only
    May 23, 2013 |Story| Reuters
  1. Denner added as nominee to Vivus board by activist investor

    Reuters
    By Bill Berkrot May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner and two others to its slate of...

    Tags: Biogen Idec Incorporated, Science and Technology, Board of Directors, Carl Icahn, Drugs and Medicines

  2. Jul 17, 2012 |Story| CNN
  3. Apr 30, 2012 |Story| South Florida Sun-Sentinel
  4. Nuevo rival para el Viagra

    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer Inc.
    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...

    Tags: Levitra (drug), GlaxoSmithKline PLC, Viagra (drug), Drugs and Medicines, Pfizer Inc.

  5. Feb 23, 2012 |Story| Reuters
  6. |Story
  7. Mar 29, 2012 |Story| Reuters
  8. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Abbott Laboratories, Drugs and Medicines, Obesity, Heart Attack, Contrave (drug)

  9. Feb 23, 2012 |Story| Reuters
  10. |Story
  11. Apr 11, 2011 |Story| Los Angeles Times
  12. Diet drug Qnexa: Don't get too carried away by new study

    The diet drug Qnexa helps obese people with weight-related medical conditions to lose more weight than those who take a dummy pill and could allow some to scale back on medications for diabetes, high blood pressure or cholesterol, according to a new study...

    Tags: Pharmaceuticals, Obesity, Drugs and Medicines, Placebo, Contrave (drug)

  13. Oct 25, 2010 |Story| Los Angeles Times
  14. FDA shoots down another weight loss drug [Updated]

    The FDA has <a title="Arena Pharmaceuticals' press release" href="http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977" target="_blank">told the makers</a> of the proposed weight-loss drug Lorcaserin&nbsp;that it will not&nbsp;at this time approve the marketing of &nbsp;the medication, citing concerns about its marginal effectiveness and about&nbsp;cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]
    The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of  the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...

    Tags: Arena Pharmaceuticals, Inc., Human Body, Health and Medical Professionals, Trials, Pharmaceuticals

  15. Sep 15, 2010 |Story| Chicago Tribune
  16. Diet drugs face tough test

    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny.
    Tribune Newspapers
    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...

    Tags: Health and Medical Professionals, Abbott Laboratories, Pharmaceuticals, Obesity, Drugs and Medicines

  17. Nov 17, 2010 |Story| Daily Press
  18. Teaming up to save your skin

    Daily Press
    Products by two Hampton Roads organizations are on the cutting edge of wound care. The nonprofit LifeNet Health in Virginia Beach offers TheraSkin, a graft made of real skin that stimulates your body to heal itself. Soluble Systems of Newport News...

    Tags: Hospitals and Clinics, Human Body, Health and Medical Professionals, Hampton Roads, Skin

  19. Sep 17, 2010 |Story| Los Angeles Times
  20. The scorecard on obesity drugs: 0 for 3

    This is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on prescription obesity drugs this year by the advisory committee.
    Los Angeles Times Staff Writer
    This is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...

    Tags: Arena Pharmaceuticals, Inc., Health and Medical Professionals, Pharmaceuticals, Obesity, Drugs and Medicines

  21. Oct 28, 2009 | Los Angeles Times
  22. Obesity drugs lumber toward marketplace

    Booster Shots
    About this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
 1  2Next >
Original site for Vivus Inc. topic gallery.